Technology: Geroscience
Industry: Drug Development, Gene therapy
Headquarters: Brisbane, California, United States
Founded Date: 2009
Employees Number: 51-100
Funding Status: Series C
Investors Number: 23
Total Funding: 210.6M
Estimated Revenue: $10M to $50M
Last Funding Date: Mar 19, 2018
Last Funding Type: Series C

Visit Website
info@unitybiotechnology.com
https://twitter.com/unitybiotech
Register and Claim Ownership